会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Amide derivative
    • 酰胺衍生物
    • US07465748B2
    • 2008-12-16
    • US10567565
    • 2004-08-05
    • Toru KontaniJunji MiyataWataru HamaguchiTomoaki KawanoAkio KamikawaHiroshi SuzukiKenji Sudo
    • Toru KontaniJunji MiyataWataru HamaguchiTomoaki KawanoAkio KamikawaHiroshi SuzukiKenji Sudo
    • A61K31/41C07D271/06
    • C07D335/02C07D413/12
    • There is provided a pharmaceutical drug, particularly a novel compound useful for prophylaxis or a therapeutic treatment of various diseases involving infections with viruses of the herpesvirus family, specifically various herpesvirus infections such as varicella (chicken pox) via varicella zoster virus, varicella zoster via recurrent infection with latent varicella zoster virus, herpes labialis and herpes encephalitis via HSV-1 and genital herpes via HSV-2 infection.An N-{2-[(4-substituted phenyl)amino]-2-oxoethyl}tetrahydro-2H-thiopyran-4-carboxamide derivative, of which phenyl group is substituted at position 4 with a specific 5- or 6-membered heteroaryl group, and a salt thereof have an effective anti-virus activity, and the oral administration thereof at a low dose enabled the therapeutic treatment of the above diseases.
    • 提供药物,特别是可用于预防或治疗涉及疱疹病毒家族病毒感染的各种疾病的新型化合物,特别是各种疱疹病毒感染如通过水痘带状疱疹病毒的水痘(水痘),水痘带状疱疹经由复发 通过HSV-1和生殖器疱疹通过HSV-2感染感染潜伏性水痘带状疱疹病毒,唇疱疹和疱疹脑炎。 N-(2 - [(4-取代苯基)氨基] -2-氧代乙基}四氢-2H-噻喃-4-甲酰胺衍生物,其苯基在4位被特定的5或6元杂芳基取代 基团和其盐具有有效的抗病毒活性,并且以低剂量口服给药能够治疗上述疾病。
    • 6. 发明申请
    • AGENT FOR PREVENTION/TREATMENT OF DISEASE CAUSED BY ACYCLOVIR-RESISTANT HERPESVIRUS
    • 预防/治疗由抗胆碱性阴道病引起的疾病的药剂
    • US20090048310A1
    • 2009-02-19
    • US11815365
    • 2006-02-01
    • Hiroshi SuzukiKoji ChonoKenji Sudo
    • Hiroshi SuzukiKoji ChonoKenji Sudo
    • A61K31/4245A61P31/22C07D409/00C07D277/62C07D277/00C07D271/06
    • A61K31/422A61K31/4245C07D413/12
    • [Problems] To provide an agent useful for the prevention or treatment of various diseases associated with the infection with acyclovir-resistant viruses of the family Herpesviridae, specifically various infectious caused by herpes viruses, such as varicella associated with varicella-zoster virus infection, herpes zoster associated with recurrent infection with latent varicella-zoster virus, and herpes labialis, herpes encephalitis and genital herpes associated with HSV-1 and HSV-2 infection, and the like.[Means for Solving Problems] An N-[2-[(4-substituted phenyl)amino]-2-oxoethyl]tetrahydro-2H-thiopyran-4-carboxamide derivative in which the phenyl group is substituted at position 4 by a specific 5- or 6-membered heteroaryl group. This derivative has an excellent anti-viral activity against acyclovir-resistant herpes viruses and, therefore, is effective for the treatment of the diseases as mentioned above.
    • [问题]提供可用于预防或治疗与疱疹病毒科疱疹病毒的无环鸟苷抗性病毒感染有关的各种疾病的药剂,特别是由疱疹病毒引起的各种感染性疾病,例如与水痘带状疱疹病毒感染相关的水痘,疱疹 与潜伏性水痘带状疱疹病毒复发感染的带状疱疹,唇疱疹,与HSV-1和HSV-2感染相关的疱疹性脑炎和生殖器疱疹等。 [解决问题的手段]将苯基在4位被特定5取代的N- [2 - [(4-取代苯基)氨基] -2-氧代乙基]四氢-2H-噻喃-4-甲酰胺衍生物 - 或6-元杂芳基。 该衍生物对抗阿昔洛韦抗性疱疹病毒具有优异的抗病毒活性,因此对于如上所述的疾病的治疗是有效的。
    • 9. 发明申请
    • PREVENTIVE OR THERAPEUTIC AGENT FOR HERPESVIRUS-RELEATED DISEASE
    • 用于治疗病毒性疾病的预防或治疗药物
    • US20090042915A1
    • 2009-02-12
    • US11815375
    • 2006-02-01
    • Hiroshi SuzukiKenji Sudo
    • Hiroshi SuzukiKenji Sudo
    • A61K31/422A61K31/4245A61K31/522A61P31/22
    • C07D413/12A61K31/422A61K31/4245A61K31/52A61K31/522A61K45/06A61K2300/00
    • [Problems] To provide a medicament, particularly a pharmaceutical composition useful for preventing or treating a variety of diseases caused by infection of a virus of the Herpesviridae family.[Means for Solving Problems] The present invention relates to an anti-herpesvirus agent characterized by combining a helicase-primase inhibitor with a polymerase inhibitor. By combining the polymerase inhibitor with the helicase-primase inhibitor having different functional mechanisms, the anti-herpesvirus agent of the present invention achieves an extremely superior anti-herpesvirus activity compared with conventional administration of a polymerase inhibitor alone. Therefore, it is particularly effective in a case in which a sufficient therapeutic effect cannot be achieved only with a polymerase inhibitor. Further, since the doses of both agents can be kept low, it is also possible to perform treatment by lowering the effect of an adverse reaction to be concerned.
    • [问题]提供一种药物,特别是可用于预防或治疗由疱疹病毒科家族病毒感染引起的各种疾病的药物组合物。 解决问题的手段本发明涉及抗疱疹病毒药物,其特征在于将解旋酶抑制剂与聚合酶抑制剂组合。 通过将聚合酶抑制剂与具有不同功能机制的解旋酶抑制剂相结合,本发明的抗疱疹病毒剂与单独使用聚合酶抑制剂相比,具有非常优异的抗疱疹病毒活性。 因此,仅在聚合酶抑制剂不能达到足够的治疗效果的情况下才有效。 此外,由于可以将两种药剂的剂量保持在较低水平,所以也可以通过降低所涉及的不良反应的效果来进行治疗。